Biotech / Gene Therapy Funding
Capvizr tracks Biotech / Gene Therapy funding activity across newly funded companies, lead investors, hiring signals, and market narratives.
Top company Typewriter TherapeuticsLargest round $56 million1 deals
Recent Biotech / Gene Therapy rounds
- Typewriter Therapeutics · $56 million · Series A · September 3, 2026
Market context
Biotech / Gene Therapy deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.
Open Biotech / Gene Therapy in the interactive Capvizr dashboard →